Lv1
30 积分 2025-06-02 加入
Cancer burden and control in China: landscape, trends and challenges
2天前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
3天前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
4天前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
22天前
已完结
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
27天前
已完结
Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature
29天前
已关闭
Divergent tumor immunity determined by bacteria-cancer cell engagement
1个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
1个月前
已完结
Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance
1个月前
已完结
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion
1个月前
已完结
皖公网安备34019202002308
